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We investigated the role of apoptosis in the development of B cell memory by analyzing the
(p-azophenylarsonate) Ars response in a line of A strain mice in which expression of human
Bcl-2 was enforced in the B cell compartment. Previous studies of the Ars immune response in
these A. Bcl-2 mice, demonstrated that a large percentage of the antibodies expressed by the Ars
induced memory B cell compartment had accumulated point mutations via somatic hypermuta-
tion that increased their affinity for both Ars and the autoantigen DNA ("dual reactive" antibod-
ies). This was in sharp contrast to normalA strain mice which displayed no dual reactive B cells
in their Ars induced memory B cell compartment. These data suggested that interference with
apoptotic pathways regulated by Bcl-2 allows developing memory B cells that have acquired
autoreactivity to bypass a peripheral tolerance checkpoint. Further studies of these mice,
reported,here, demonstrate that enforced expression of Bcl-2 does not alter serum antibody
affinity maturation nor positive selection of B cells expressing somatically mutated antibody
with an increased affinity for Ars. Moreover, the somatic hypermutation process was unaffected
in A. Bcl-2 mice. Thus, enforced expression of Bcl-2 in A. Bcl-2 mice appears to selectively
alter a negative selection process that operates during memory B cell differentiation.
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INTRODUCTION
Upon activation by antigen, mature B-lymphocytes
migrate to the primary follicle and establish distinct
microenvironments known as germinal centers (GCs).
Once located in the GC, B cells undergo a series of
differentiation events. One of these events is the acti-
vation of a somatic hypermutation mechanism, which
rapidly introduces point mutations into Ig variable
(V) regions (Tsiagbe et al., 1996). Although not com-
pletely random, somatic hypermutation can result in
various V region phenotypes. For instance, some
mutations may disrupt the structural integrity of the V
region leading to a loss of function (Manser et al.,
1987a; Schlomchik et al., 1989), whereas others can
result in an increase in antibody affinity (Berek et al.,
1987; Sharon et al., 1989; Weiss et al., 1990). These
high affinity variants provide the substrate for serum
antibody affinity maturation. In addition, certain
mutations can often fortuitously generate V regions
with an autoreactive phenotype (Casson and Manser,
1995; Hande and Manser 1997).
B cells in the GC have also been demonstrated to
exhibit a high incidence of apoptosis (MacLennan,
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1994) which is believed to mediate the disappearance
of low affinity V region mutants, autoreactive
mutants, or both. The susceptibility of GC B cells to
apoptosis can be attributed to factors such as the
absence of the anti-apoptotic protein Bcl-2 (Mar-
tinez-Valdez et al., 1996) and high expression of Fas
(CD95) (Tsiagbe et al., 1996). Evidence to support the
sensitivity of GC B cells to apoptotic signals has also
been demonstrated in studies where GC B cells inter-
act with high levels of cognate soluble antigen in situ
(Pulendran et al., 1995; Shokat and Goodnow, 1995;
Han et al., 1995); a situation argued to mimic a form
of tolerance induction in vivo.
During the immune response to the hapten Ars in A/J
mice, there is the predominance of a particular clono-
type termed the canonical clonotype (Manser et al.,
1987b; Rathbun et al., 1989; Wysocki et al., 1987).
Canonical antibodies are composed of specific heavy
and light chainV regions that prior to somatic mutation,
differ only at their VH-D and D-JH segment junctions.
Previous in vitro mutagenesis studies of canonical
monoclonal antibodies (mAbs) have illustrated that
certain mutations in the CDRs often result in simultane-
ous increases in the affinity for foreign (Ars) and self
(DNA) antigen (Casson and Manser, 1995; Hande and
Manser 1997). However, previous in vivo data revealed
that such "dual" reactive canonical antibodies are absent
from the Ars-induced memory B cell compartment
(Naparstek et al., 1986). Suggesting therefore, that dual
reactive mutants were absent from the memory com-
partment of normal healthy individuals due to the action
of a peripheral tolerance checkpoint. In order to test this
hypothesis we have studied the immune response to Ars
inA strain mice which constitutively expressed Bcl-2 in
the B cell compartment.
Initial analyses of the Ars response in A.Bcl-2 mice
indicated that most aspects of this response were not
overtly altered. Participation of canonical anti-Ars
clonotypes in the immune response and somatic
mutation of canonical antibodies appeared compara-
ble to normal A strain mice (Hande et al., 1998).
However, whereas dual reactive hybridomas are not
isolated from secondary and tertiary fusions from A
strain mice, such hybridomas made up approximately
25% of the canonical expressing secondary and terti-
ary hybridomas isolated from A.Bcl-2 mice (Hande et
al., 1998). These data suggested that altering apopto-
sis obstructs negative selection of dual reactive clones
in the periphery.
B cell tolerance has also been studied in other
transgenic mouse lines in which Bcl-2 expression is
enforced in the B cell compartment. In particular, a
recent study by Kuo et al., (1999) suggests that alter-
ing Bcl-2 expression affects central tolerance but does
not affect peripheral tolerance. Specifically, dual reac-
tive anti-DNA, anti-phosphorylcholine (PC) B cells
could be recovered by hybridoma technology late in
the primary response but did not appear in the anti-PC
memory B cell compartment (Kuo et al., 1999). Addi-
tional studies from the same group also argue that
although Bcl-2 does not affect the frequency of
somatic mutation, it impairs the clustering of muta-
tions to "hot spot" motifs (Kuo et al., 1997). In addi-
tion to Bcl-2 transgenics, maturation of the B cell
response has also been investigated in mice
over-expressing the anti-apoptotic protein Bcl-xL in B
cells (Fang et al., 1996). Studies of these transgenic
mice demonstrated that over-expression of Bcl-xL
alters affinity maturation allowing low affinity B cells
to participate in the response (Takahashi et al., 1999).
Given these observations of others, one could argue
that if positive selection, somatic mutation, or both
are altered by enforced expression of Bcl-2 in A.
Bcl-2 mice, then the effects on the frequency of
Ars-induced "dual reactive" antibodies could be indi-
rect. For instance, if the pattern of somatic mutation
in a V gene was altered by Bcl-2, the frequency of
"dual reactive" antibodies encoded by that V gene
might change. Alternatively, if enforced expression of
Bcl-2 lowered the "stringency" of positive selection,
dual reactive B cells, which would be expected to
bind less stimulatory foreign antigen due to "receptor
blockade" by self antigen(s) might nevertheless enter
the memory B cell compartment.
For these reasons, we decided to closely examine
positive selection and V region hypermutation in A.
Bcl-2 mice undergoing an Ars immune response. We
found that canonical antibodies elicited in these mice
displayed a normal frequency of V region somatic
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tional "hot spots". We also observed an increase in
serum antibody affinity, which was comparable to nor-
mal controls. In addition to the existence of dual reac-
tive canonical antibodies, the conventional (Ars+
DNA-) canonical antibodies expressed in the memory
B cell compartment displayed increased affinity for
Ars due to somatic mutation. Therefore, our results
suggest that apoptotic pathways regulated by Bcl-2 do
not influence the mechanisms or the regulation of
somatic hypermutation or positive selection of anti-
body mutants with increased affinity.
RESULTS
Bcl-2 Transgene Expression Is Predominant In
The B Cell Compartment of A. Bcl-2 Mice
To obtain A strain mice with constitutive B cell expres-
sion of Bcl-2, the M23 Bcl-2 transgenic mouse line
(Smith et al., 1994) was backcrossed to the A/J mouse
strain for 4-6 generations. The M23 transgene is a
reconstruction of the t(14;18)(q32;q21) translocation
observed in B cell lymphomas and has a central region
ofhuman Bcl-2 cDNA that contains the exon II exon
III juncture (McDonnell et al., 1989). The expression
of the human Bcl-2-Ig fusion "minigene" allows the
expression of transgene encoded Bcl-2 protein to be
unambiguously distinguished from endogenous mouse
Bcl-2 expression. To evaluate this expression, immu-
nohistochemical staining was performed on frozen
spleen sections from 5-week-old naive A.Bcl-2 mice,
using a mouse IgG1 mAb that recognizes human Bcl-2
protein followed by a goat anti-mouse IgG mAb.
Transgenic Bcl-2 expression was predominantly local-
ized in follicles, including GCs, with a more scattered
expression in the PALS and red pulp (Figure 1A). As
expected, transgene negative littermates displayed only
occasional IgG positive B cells (Figure 1B).
Levels Of Serum Autoantibodies In A. Bcl-2 Mice
Are Comparable To Control Littermates
In our initial study, we used a hybridoma approach to
evaluate how positive and negative selection events
FIGURE Immunohistochemical Analysis Of Transgene Expres-
sion In Naive Spleens From A. Bcl-2 Mice. Spleen sections of a 5
week old A.Bcl-2 mouse (A) and a 5 week old control littermate
(B) were stained for the expression ofhuman Bcl-2 protein (stained
blue) and germinal centers (GCs) (stained red). A.Bcl-2 mice heav-
ily expressed the human Bcl-2 protein in their follicles and GCs,
and exhibited sporadic expression in other regions of the spleen,
such as the red pulp. As expected, control littermates exhibited no
expression of the transgene and only show sporadic presence of
IgG1 positive cells
may be altered during the maturation of the anti-Ars
response in A. Bcl-2 mice (Hande et al., 1998). The
vast majority of the canonical hybridomas isolated
expressed mAbs that were class-switched, had under-
gone extensive somatic mutation and were Ars bind-
ing. In addition, data from this analysis demonstrated
that altering apoptotic pathways regulated by Bcl-2
allowed for the entry of dual reactive B cells into the
memory compartment. Sequence analysis of the
Ars-DNA binding V regions that were isolated
revealed that the overall pattern of somatic mutation
did not differ from that observed in the V regions iso-
lated from the memory compartment of normal A
strain mice (Manser, 1991). Several of these dual226 EVANGELIA NOTIDIS et al.
reactive mAbs also displayed relative DNA binding
that was as good as or better than the autoantibody
3H9 which was isolated from a diseased MRL lpr/lpr
mouse (Shlomchik et al., 1987). Thus, enforced Bcl-2
expression in the B cell compartment allowed for the
expansion of canonical dual reactive B cells. Conse-
quently, we decided to investigate whether these B
cells produced any serum antibody.
We primed both A.Bcl-2 mice and transgene nega-
tive control littermates with Ars-KLH in CFA. The
mice were then bled, boosted with Ars-KLH in PBS
and bled again following secondary and tertiary
immunizations. Bulk anti-ssDNA, anti-dsDNA, and
anti-Ars antibody titers were then determined and
compared between A.Bcl-2 mice (Figure 2A-2C) and
control littermates (Figure 2D-2F). As is shown in
Figure 2A-2F and in our previous analysis (Hande et
al., 1998), the serum antibody levels in both groups
are comparable, with a slight increase in the level of
anti-ssDNA and anti-dsDNA antibodies in the A.
Bcl-2 mice during tertiary immune responses
(Figure 2C). This increase may be attributed to the
overall increase in serum Ig, which is observed in
these mice during a tertiary immune response
(Figure 3B). This is in accord with previous studies of
Bcl-2 transgenic mice, which demonstrated that they
have a prolonged AFC response (Smith et al., 1994)
and that they display mild hypergammaglobulinemia
with age (McDonnell et al., 1989). Previous studies
on autoreactive Ig transgenic mouse models have
demonstrated that although B cells with a low affinity
for DNA persist in the periphery and can be rescued
as hybridomas, they do not produce serum antibody
(Erikson et al., 1991). Hence, although our previous
studies showed that Ars-DNA dual reactive antibod-
ies could be isolated at the level of hybridomas, they
could not be detected in the serum after Ars immuni-
zation, suggesting that dual reactive B cells, like
anti-DNA Ig transgenic B cells, are regulated such
that they do not secrete antibody.
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FIGURE 2 Binding Activities Of Antibodies In Sera Of A.Bcl-2 Mice And Control Littermates Following Immunization With Ars-KLH
Pooled sera from four to eight A.Bcl-2 mice (A-C) and four to five control littermates (D-F) were analyzed for anti-Ars, anti-ss and
anti-dsDNA IgG titers prior to immunization, and after primary (day 8) and tertiary (day 7) immunizations with Ars-KLH. Antibody titers
were similar between the two groups prior to immunization and after primary immunization, whereas A. Bcl-2 mice expressed a slight
increase over their control littermates after the tertiary immunization
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FIGURE 3 Total Serum Immunoglobulin In A. Bcl-2 Mice And Control Littermates. Total serum immunoglobulin was compared between
A.Bcl-2 mice and control littermates prior to Ars-KLH immunization at 8 weeks old (A) and after tertiary Ars-KLH immunization at 6
months of age (B). Levels of total serum Ig antibody was comparable in both groups prior to immunization, whereas A. Bcl-2 mice express
slightly elevated levels of serum Ig following a tertiary response. Increased levels of total serum Ig can be attributed to the incidence of the
mild hypergammaglobulinemia that is associated with age in M23 transgenic mice (McDonnell et al., 1989)
Serum Antibody In A. Bcl-2 Mice Shows Evidence
Of Affinity Maturation
In order to examine antibody affinity maturation in A.
Bcl-2 mice, sera from A.Bcl-2 mice undergoing
immune responses to Ars-KLH were analyzed by an
altered ligand density ELISA. High affinity serum
antibody will be distinguished from low affinity
serum antibody since high affinity serum antibody
will bind equally well to both hapten densities. Con-
versely, low affinity antibody will bind densely conju-
gated protein much better than sparsely conjugated
protein. The relative affinities of the serum antibodies
were compared to the affinities of 36-65, an unmu-
tated canonical mAb and to 36-71, a canonical mAb
which possesses mutations that increase its affinity
for Ars 100-fold (Vora and Manser, 1995).228 EVANGELIA NOTIDIS et al.
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FIGURE 4 Altered Ligand Density ELISA To Measure Serum Antibody Affinity Maturation. Affinity maturation of Ars specific serum anti-
body of pooled A.Bcl-2 and control serum following secondary immunization with Ars-KLH was determined by altered ligand density
ELISA. Pooled sera from A.Bcl-2 mice (A) and strain A transgene negative mice (B) following a secondary immunization with Ars-KLH
was tested on a densely conjugated (open circles) and a sparsely conjugated (closed circles) preparation of BSA. The ratio of the 50% bind-
ing points of the two differdnt curves for each group was 0.4 for A.Bcl-2 mice and 0.32 for transgene negative control mice. These curves
were compared to the binding ratios of 36-65 (Ka 3 x 105) which was approximately 0.03 and 36-71 (Ka 2 x 107) which was
Figure 4 panels A and B demonstrate evidence of
normal affinity maturation in the serum antibody of
A.Bcl-2 mice. The relative position of the Ars binding
curves obtained using either low or high Ars protein
conjugates were similar in the case of secondary sera
obtained from A.Bcl-2 transgenic mice and strain A
transgene negative controls. The near superimposition
of the binding curves obtained for the low and high
Ars protein conjugates indicate a predominant pres-
ence of high affinity Ars antibody in these sera (see
legend for details).
Evidence For Normal Positive Selection OfB Cells
With Increased Affinity In A. Bcl-2 Mice
In order to determine whether Ars-driven positive
selection was altered in A.Bcl-2 mice, we decided to
examine memory B cells expressing canonical anti-
bodies which did not display an affinity for DNA, as
determined by ELISA (data not shown). Using the
hybridoma approach, we isolated 15 such canonical
mAbs from two different A.Bcl-2 mice undergoing a
secondary Ars response. All 15 hybridomas expressed
IgG antibodies.
A sample of the non-DNA binding canonical mAbs
isolated was then chosen forVH gene sequence analy-
sis. As indicated in Figure 5, all of the hybridomas
analyzed showed evidence of somatic mutation in
their VH genes. One of the hybridomas, 10-5-A9,
also possesses affinity-enhancing mutations at posi-
tions 58 and 59 in CDR2. Specifically, the VH gene it
expresses contains the Thr58- lie and Lys59- Thr
mutations that have previously been shown to result
in an increase in affinity for Ars (Sharon et al., 1989).BCL-2 PERTURBS NEGATIVE SELECTION OF DUAL REACTIVE ANTIBODIES 229
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FIGURE 5 Sequences Of ,The VH Regions Of Ars DNA- Canonical mAbs. These sequences were determined as described in Materials and
Methods and are shown as compared to the unmutated canonical consensus VH gene sequence. The nucleotides that vary among canonical
antibodies at the V-D and D-J junctions are indicated with Xs. Sequence identity is indicated by a dash and differences are shown explicitly.
The VH gene expressed by hybridoma 10-5-A9 also contains the affinity enhancing mutations at positions 58 and 59
TABLE K Values Obtained For Ars DNA- Hybridomas By
Fluorescence Quenching Analysis
Mouse mAb Name Kafor Ars-Tyr(M-1)
5Bcl-9
5Bcl-10
Unmutated canonical (36-65) 3.7 x 10
9-l-A1 1.6 x 106
9-2-B4 8.0 x 106
10-5-C1 1.6 x 106
10-3-H8 1.7 x 106
10-8-A6 1.5 106
To examine directly whether there was Ars mediated
positive selection of canonical expressing B cells in A.
Bcl-2 mice, another sample of the canonical Ars+DNA
hybridomas were selected for fluorescence quenching
analysis of their expressed mAbs (Table I). As shown in
Table I, all of the Ka values obtained for these mAbs
were greater than 106 M-1. The average affinity for
these antibodies was 2.9 106 M-1, which is approxi-
mately a 10-fold increase over the affinity characteristic
of unmutated canonical V regions, such as the mono-
clonal antibody, 36-65. Such an increase in affinity is
characteristic of affinity matured, canonical V regions
isolated from Ars-immunized A/J mice (Manser, 1991).
Enforced Bcl-2 Expression Does Not Affect
Clustering OfMutations In Mutational "Hot Spots"
Somatic hypermutation of Ig genes is not a com-
pletely random process. Rather, numerous studies
have demonstrated that somatic mutation targets par-
ticular "hot spot" motifs (Smith et al., 1996; Rogozin
and Kolchanov 1992; Betz et al., 1993; Shapiro et al.,
1999). Other studies on Bcl-2 transgenic mice have
suggested that although the frequency of V region230 EVANGELIA NOTIDIS et al.
somatic mutation was normal, the clustering of muta-
tions to "hot spot" motifs was impaired (Kuo et al.,
1997). Therefore we decided to compare the muta-
tional frequency and the clustering of mutations to
mutational "hot spots" of normal A strain mice to A.
Bcl-2 transgenic mice. The sequences chosen for this
analysis were from a collection of secondary and ter-
tiary canonical expressing anti-Ars hybridomas.
Recent reports have identified a number of tri- and
tetra nucleotide consensus sequences that appear to be
targeted for mutation (Smith et al., 1996). We exam-
ined the mutations clustered in the tri-nucleotide "hot
spots" AGC, TAC, GCT and GTA (Table II) (Smith et
al., 1996). In addition, we also examined the level of
mutational clustering found at the mutational hot spot
designated by the motif purine/G/pyrimidine/A or T
orRGYW (Rogozin and Kolchanov 1992) (Table II).
The average percentage of mutations clustered at
the tri-nucleotide hot spots AGC/TAC/GCT/GTA for
A. Bcl-2 mice was 26%, compared to normal A strain
mice which had an average percentage of 22%. Thus,
the percentages of mutations clustered at these muta-
tional "hot spot" motifs between the two groups were
comparable (Table II). The same conclusion can also
be drawn from the comparison made at the mutational
hot spotRGYW where the average percent of cluster-
ing for the V genes obtained from A.Bcl-2 mice was
37%, compared to controls, which was 32%. The
mutational frequencies between the two groups were
also comparable, where VH genes from A/J mice had
a mutation frequency of 2.0% and those from A.Bcl-2
mice had a frequency of 1.9%. Therefore, enforced
expression of Bcl-2 in A.Bcl-2 mice does not overtly
alter the frequency of somatic mutation or "targeting"
of these mutations to hot spots.
DISCUSSION
Preliminary studies using A.Bcl-2 mice indicated that
most aspects of the Ars immune response in these mice
were comparable to those in non-transgenic A strain
mice. Specifically, there was normal participation of
the predominant canonical clonotype of the Ars
response, comparable levels of anti-Ars serum antibod-
ies, and somatic hypermutation took place in canonical
antibody expressing GCs (Hande at al., 1998). Overall,
our data were in accord with previous findings, which
suggested that many of the antigen-driven stages of T
cell dependent B cell differentiation are unaffected in
Bcl-2 transgenic mice (Smith et al., 1994).
However, unlike normal A strain mice which lack
Ars-DNA dual specific antibody expressing B cells in
their memory compartment, such B cells were readily
detected in the memory compartment of A.Bcl-2 mice
(Hande at al., 1998). These findings stand in contrast to
those obtained from studies of the anti-PC response in
Etbcl-2-22 transgenic BALB/c mice. Kuo, et al.,
(1999) isolated PC-DNA dual reactive B cell hybrido-
mas during the late primary response to PC, but failed
to do so in the secondary response. However, unlike the
dual reactive hybridomas we had previously isolated,
those isolated by Kuo, et al., (1999) were encoded by
unmutated VH genes; suggesting that expression of
Bcl-2 in these transgenic mice allows dual reactive B
cells to escape central tolerance in the bone marrow.
Conversely, our studies indicated that the over-expres-
sion of Bcl-2 resulted in dual reactive B cells escaping
some form of peripheral tolerance, since all of the
hybridomas isolated had evidence of somatic hypermu-
tation (Hande at al., 1998).
TABLE II Clustering Of Mutations To Mutational "Hot Spots"
AGC/TAC/GTA/GCT purine/G/pyrimidines/A or T (RGYW)
Mouse Line Hot Spot Non-Hot Spot Hot Spot Non-Hot Spot
Mutations Mutations Mutations Mutations
Total Base
Pairs
Mutation
Frequency
CONTROL MICE 68 (22%) 238 97 (32%) 209
A. BCL-2 MICE 38 (26%) 109 50 (37%) 87
15,360
7920
2.0%
1.9%
a. Canonical VH gene from codons 17-98.
b. Percentages of mutations clustered at mutational hot spots for each group are specified in parentheses.BCL-2 PERTURBS NEGATIVE SELECTION OF DUAL REACTIVE ANTIBODIES 231
The apparent contradictions of the observations
between our results and those of Kuo et al., (1999)
may be attributed to both differences in the nature of
the transgenic mice and the antigen systems used for
these studies. For example, the Egbcl-2-22 transgene
is driven by the SV40 promoter and was present on
the BALB/c background whereas the M23 Bcl-2
transgene is driven by the human Bcl-2 promoter and
was present on the strain A background. The use of
different promoters may result in different levels of
expression at specific stages of B cell differentiation
contributing to the conflicting outcomes. In addition,
alteration of genetic background has been previously
shown to influence the effects of enforced Bcl-2
expression on the development of autoimmunity
(Strasser et al., 1992). Furthermore, the VHS107
expressing clonotype that dominates the PC response
in BALB/c mice does not appear to undergo affinity
maturation, whereas canonical anti-Ars clonotypes in
A/J mice clearly do. Therefore, most somatically
mutated forms of the VHS107 expressing clonotype,
including dual reactive cells, may lack the affinity
requisite for selectidn into the memory B cell com-
partment.
Although dual reactive hybridomas were easily iso-
lated from Ars-immunized A. Bcl-2 mice, there were
no significant elevations of serum anti-DNA antibod-
ies in these mice. In this case our results are consistent
with those of the anti-PC response in Egbcl-2-22
transgenic BALB/c mice, which reported that titers of
serum anti-DNA antibodies in these mice did not rise
following primary or secondary PC immunizations
(Kuo at al., 1990). Erikson et al., (1991) have also
reported that in mice transgenic for the 3H9 heavy
chain, transgene expressing B cells with a low affinity
for DNA are resident in the periphery and can be iso-
lated as hybridomas, but produce undetectable levels
of serum antibody. Further analysis of the same trans-
gene expressing B cells, demonstrated that they were
phenotypically distinct from non-transgenic B cells
and that they were functionally compromised
(Nguyen et al., 1997).
Hence, the inability of dual reactive cells in A.
Bcl-2 mice to secrete antibody may be a consequence
of a defect or defects in Ig-mediated signaling due to
chronic autoantigen engagement. Reduced surface
levels of co-stimulatory receptors, which play a role
in modulating the response through the Ig receptor,
may alter the signaling threshold of such cells when
stimulated through membrane Ig. Alternatively,
sIg-mediated signaling may be defective, as demon-
strated using other autoreactive Ig transgenic systems
(Cooke et al., 1994). Particularly, it has been demon-
strated that anergic B cells exhibit a proximal block in
the sIg signaling pathway which prevents activation
of receptor-associated tyrosine kinases in response to
soluble antigen (Cooke at al., 1994). Whether dual
-reactive B cells in A.Bcl-2 mice are anergic due to a B
cell receptor signaling defect will require further
study.
The anti-Ars serum antibodies that were elicited in
A.Bcl-2 mice also exhibited evidence of normal affin-
ity maturation. This is in accordance with earlier stud-
ies of the (4-hydroxy-3-nitrophenyl)acetyl (NP)
response in Egbcl-2-22 C57B1/6 transgenic mice,
which demonstrated that affinity maturation to the
hapten NP was not affected by over-expression of
Bcl-2 (Smith et al., 1994). In contrast, studies of the
NP response in Bcl-xL transgenic mice have shown
that over-expression of Bcl-xL influences affinity
maturation (Takahashi et al., 1999). In these studies it
was observed that low affinity anti-NP clonotypes
predominantly participated in the anti-NP response of
Bcl-xL mice whereas these clonotypes were minor
participants in the NP response of control mice.
The differences in the observed effect of enforced
Bcl-2 and Bcl-xLexpression may be attributed to the
unique functions of these two different anti-apoptotic
proteins. Although the proteins are members of the
same family, they appear to function independently of
one another and at different stages of B cell develop-
ment. For example, GC B cells have been demon-
strated to down regulate Bcl-2 expression while
Bcl-xL has been shown to be expressed in the centro-
cyte subset of these B cells (Tuscano et al., 1996). If
positive and negative selection of antibody V region
mutants take place at distinct stages of the GC reac-232 EVANGELIA NOTIDIS et al.
tion, these processes may be differentially altered by
enforced or over-expression of regulatory factors that
normally act at specific stages of this reaction.
A detailed analysis of the somatic mutations
present in the VHgenes expressed by a panel of hybri-
domas isolated from the anamnestic response of A.
Bcl-2 mice revealed clustering of mutations to muta-
tional hot spots at a frequency similar to controls. In
contrast, studies from Kuo et al., (1997) using
Ebcl-2-22 transgenic BALB/c mice and the anti-PC
GC B cell response, suggested that this normal hot
spot clustering was perturbed by enforced Bcl-2
expression. As mentioned above, differences in the
nature of the transgenic mice and antigen systems uti-
lized may influence experimental outcomes of this
type. In addition, Kuo at al., (1997) sampled the V
genes expressed by GC B cells whereas our studies
utilized hybridomas derived from anamnestic
responses. We are currently directly examining the
nature of somatic mutations introduced into canonical
V regions during the anti-Ars primary GC response of
A.Bcl-2 mice to determine if differences in hot spot
clustering are apparent at this stage of B cell differen-
tiation. Irrespective of the results of this study, our
current data strongly suggest that B cells that are
selected into the memory compartment undergo unal-
tered V region hypermutation in A.Bcl-2 transgenic
mice. Therefore, alteration of the hypermutation proc-
ess is unlikely to account for the dramatically
increased frequency of dual reactive B cells in the
memory compartment of these mice.
In total, our observations suggest that over-expres-
sion of Bcl-2 in the B cell compartment does not alter
most aspects of a T cell dependent B cell response,
including somatic hypermutation, serum antibody
affinity maturation, and positive selection of high
affinity B cells into the memory compartment. How-
ever, over-expression of Bcl-2 does perturb negative
selection, ultimately allowing dual reactive B cells to
enter this compartment. Thus, our studies suggest that
positive and negative selection are two independent
mechanisms working in concert to ensure the forma-
tion of a memory B cell population composed of B
cells with an increased specificity for foreign antigen.
MATERIALS AND METHODS
Serology and mAb Binding Assays
Mice were immunized with 100g Ars (p-azopheny-
larsonate)-KLH emulsified in CFA for the induction
of primary responses and subsequently boosted with
50tg Ars-KLH in PBS for secondary and tertiary
responses. Mice were bled via the retro-orbital sinus
and Ars and DNA reactivities were analyzed by
ELISA as described (Hande et al., 1998). Antibodies
were elaborated using peroxidase-conjugated goat
anti-mouse IgG (Jackson Immunoresearch, Inc. West
Grove, PA) followed by o-phenylenediamine (Sigma
Chemical Co. St. Louis MO). Affinity maturation of
serum antibodies was determined by an altered ligand
density ELISA, using two different coupling ratios of
Ars to BSA. The bound antibodies were elaborated
with a rat anti-mouse kappa antibody followed by
Streptavidin-alkaline phosphatase (Southern Biotech-
nology Associates, Birmingham, AL).
Immunohistochemistry
Spleens were removed, flash frozen, and sectioned as
previously described (Hande et al., 1998). Frozen sec-
tions were thawed, rehydrated and treated as before.
To determine Bcl-2 transgene expression, sections
were incubated with a mouse anti-human Bcl-2 anti-
body (Genosys Biotechnologies, The Woodlands,
TX), which was then detected with biotinylated goat
F(ab’)2 anti-mouse IgG (Southern Biotechnology
Associates, Inc. Birmingham, AL). The slides were
incubated with the antibodies for one hour. The slides
were washed in TBS-BSA and then incubated with
Streptavidin-Alkaline Phosphatase (AP) (Southern
Biotechnology Associates, Inc. Birmingham, AL) for
one hour. Germinal centers were identified with pea-
nut agglutinin (PNA) coupled to horseradish peroxi-
dase (HRP) (E-Y Laboratories, San Mateo, CA).
Bound AP and HRP activities were visualized using
Napthol AS-MX/Fast Blue BB Base and 3-ami-
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Determination ofmAb Affinity
The affinities of purified Ars mAbs were determined
by fluorescence quenching using Ars-N-acetyl-L-tyro-
sine as described before (Manser 1989). Ars affinities
were calculated using a curve-fitting program provided
by Jackie Sharon (Boston University School of Medi-
cine, Boston, MA) as described previously (Rothstein
and Gefter, 1983).
Reverse Transcriptase-PCR and Nucleotide
Sequencing
Total RNA was made from hybridomas as previously
described (Manser, 1989) and then subjected to
reverse transcriptase-PCR. VH and V: PCR amplifi-
cation was done using primers described previously
(Hande et al., 1998). The RT-PCR products were puri-
fied from agarose gels using the Qiaex II Gel Extrac-
tion Kit (Qiagen, Chatsworth, CA) according to the
manufacturer’s instructions and were sequenced using
the "fmol" sequencing kit (Promega Biotech Corp,
Madison, WI).
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